1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. Executive Summary
3.1. Outlook in the Specialty Drug Distribution Market
3.2. Opportunities in the Specialty Drug Distribution Market
4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter's Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. France Specialty Drug Distribution Market: Indication Estimates & Trend Analysis
5.1. Overview
5.2. Market Sizing & Forecasting
6. France Specialty Drug Distribution Market: Type Estimates & Trend Analysis
6.1. Overview
6.2. Market Sizing & Forecasting
7. France Specialty Drug Distribution Market: Distribution Type Estimates & Trend Analysis
7.1. Overview
7.2. Market Sizing & Forecasting
8. France Specialty Drug Distribution Market: Distribution Channel Estimates & Trend Analysis
8.1. Overview
8.2. Market Sizing & Forecasting
9. Competitive Landscape
9.1. 360iResearch FPNV Positioning Matrix for France Specialty Drug Distribution Market
9.2. Market Vendor Ranking Analysis for France Specialty Drug Distribution Market
9.3. Competitive News Feed Analysis for France Specialty Drug Distribution Market
9.3.1. Mergers & Acquisitions
9.3.2. New Product Launches
9.3.3. Business Expansions
9.3.4. Partnerships, Agreements & Collaborations
10. Company Usability Profiles
10.1. AmerisourceBergen Corporation
10.1.1. Business Overview
10.1.2. FPNV Scorecard
10.1.3. Business SWOT
10.1.4. Business Strategy
10.2. Cardinal Health, Inc.
10.2.1. Business Overview
10.2.2. FPNV Scorecard
10.2.3. Business SWOT
10.2.4. Business Strategy
10.3. McKesson Corporation
10.3.1. Business Overview
10.3.2. FPNV Scorecard
10.3.3. Business SWOT
10.3.4. Business Strategy
10.4. Rochester Drug Cooperative, Inc.
10.4.1. Business Overview
10.4.2. FPNV Scorecard
10.4.3. Business SWOT
10.4.4. Business Strategy
10.5. Smith Drug Co., Inc.
10.5.1. Business Overview
10.5.2. FPNV Scorecard
10.5.3. Business SWOT
10.5.4. Business Strategy
10.6. Aceto Corporation
10.6.1. Business Overview
10.6.2. FPNV Scorecard
10.6.3. Business SWOT
10.6.4. Business Strategy
10.7. CFAO Group
10.7.1. Business Overview
10.7.2. FPNV Scorecard
10.7.3. Business SWOT
10.7.4. Business Strategy
10.8. Mercer, Inc.
10.8.1. Business Overview
10.8.2. FPNV Scorecard
10.8.3. Business SWOT
10.8.4. Business Strategy
10.9. Mylan N.V.
10.9.1. Business Overview
10.9.2. FPNV Scorecard
10.9.3. Business SWOT
10.9.4. Business Strategy
10.10. Sanofi S.A.
10.10.1. Business Overview
10.10.2. FPNV Scorecard
10.10.3. Business SWOT
10.10.4. Business Strategy
11. Appendix
11.1. Discussion Guide
11.2. Top Reports
11.3. Author Details